{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:19:58Z","timestamp":1793387998315,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08850-x","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:34:17Z","timestamp":1761928457000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Irisin inhibits dopaminergic neuron lactate metabolism and repairs mitochondrial function to alleviate Parkinson\u2019s disease by activating SIRT1 signaling pathway"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3825-3935","authenticated-orcid":false,"given":"Lijun","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rujia","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"8850_CR1","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S. & Klein, C. Parkinson\u2019s disease. Lancet 397, 2284\u20132303 (2021).","journal-title":"Lancet"},{"key":"8850_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123088","volume":"357","author":"R Qiu","year":"2024","unstructured":"Qiu, R. et al. Irisin\u2019s emerging role in Parkinson\u2019s disease research: a review from molecular mechanisms to therapeutic prospects. Life Sci. 357, 123088 (2024).","journal-title":"Life Sci."},{"key":"8850_CR3","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.14336\/AD.2020.0216","volume":"11","author":"X Li","year":"2020","unstructured":"Li, X., Feng, Y., Wang, X. X., Truong, D. & Wu, Y. C. The critical role of SIRT1 in Parkinson\u2019s disease: mechanism and therapeutic considerations. Aging Dis. 11, 1608\u20131622 (2020).","journal-title":"Aging Dis."},{"key":"8850_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(23)01478-2","volume":"403","author":"HR Morris","year":"2024","unstructured":"Morris, H. R., Spillantini, M. G., Sue, C. M. & Williams-Gray, C. H. The pathogenesis of Parkinson\u2019s disease. Lancet 403, 293\u2013304 (2024).","journal-title":"Lancet"},{"key":"8850_CR5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1196\/annals.1427.037","volume":"1147","author":"C Henchcliffe","year":"2008","unstructured":"Henchcliffe, C. et al. Multinuclear magnetic resonance spectroscopy for in vivo assessment of mitochondrial dysfunction in Parkinson\u2019s disease. Ann. N. Y. Acad. Sci. 1147, 206\u2013220 (2008).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"8850_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fnagi.2020.00075","volume":"12","author":"C Yang","year":"2020","unstructured":"Yang, C. et al. Brain-region specific metabolic abnormalities in Parkinson\u2019s disease and levodopa-induced dyskinesia. Front. Aging Neurosci. 12, 75 (2020).","journal-title":"Front. Aging Neurosci."},{"key":"8850_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2021.105605","volume":"163","author":"J Li","year":"2022","unstructured":"Li, J. et al. Upregulated hexokinase 2 expression induces the apoptosis of dopaminergic neurons by promoting lactate production in Parkinson\u2019s disease. Neurobiol. Dis. 163, 105605 (2022).","journal-title":"Neurobiol. Dis."},{"key":"8850_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101684","volume":"5","author":"B Lian","year":"2024","unstructured":"Lian, B. et al. SIRT1 improves lactate homeostasis in the brain to alleviate parkinsonism via deacetylation and inhibition of PKM2. Cell Rep. Med. 5, 101684 (2024).","journal-title":"Cell Rep. Med."},{"key":"8850_CR9","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1523\/JNEUROSCI.1384-17.2017","volume":"38","author":"M Pinto","year":"2018","unstructured":"Pinto, M., Nissanka, N. & Moraes, C. T. Lack of Parkin anticipates the phenotype and affects mitochondrial morphology and mtDNA levels in a mouse model of Parkinson\u2019s disease.  J. Neurosci. 38, 1042\u20131053 (2018).","journal-title":"J. Neurosci."},{"key":"8850_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1038\/s41419-024-06617-6","volume":"15","author":"S Barnhoorn","year":"2024","unstructured":"Barnhoorn, S. et al. Orthogonal analysis of mitochondrial function in Parkinson\u2019s disease patients. Cell Death Dis. 15, 243 (2024).","journal-title":"Cell Death Dis."},{"key":"8850_CR11","doi-asserted-by":"publisher","unstructured":"Choong, C. J. & Mochizuki, H. Involvement of mitochondria in Parkinson\u2019s disease. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms242317027 (2023).","DOI":"10.3390\/ijms242317027"},{"key":"8850_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2023.100233","volume":"17","author":"KI Avgerinos","year":"2023","unstructured":"Avgerinos, K. I., Liu, J. & Dalamaga, M. Could exercise hormone irisin be a therapeutic agent against Parkinson\u2019s and other neurodegenerative diseases?. Metab. Open 17, 100233 (2023).","journal-title":"Metab. Open"},{"key":"8850_CR13","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1136\/bjsports-2016-097132","volume":"51","author":"T Pasanen","year":"2017","unstructured":"Pasanen, T., Tolvanen, S., Heinonen, A. & Kujala, U. M. Exercise therapy for functional capacity in chronic diseases: an overview of meta-analyses of randomised controlled trials. Br. J. Sports Med. 51, 1459\u20131465 (2017).","journal-title":"Br. J. Sports Med."},{"key":"8850_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.exger.2018.01.024","volume":"104","author":"JH Kim","year":"2018","unstructured":"Kim, J. H. & Kim, D. Y. Aquarobic exercises improve the serum blood irisin and brain-derived neurotrophic factor levels in elderly women. Exp. Gerontol. 104, 60\u201365 (2018).","journal-title":"Exp. Gerontol."},{"key":"8850_CR15","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2204835119","volume":"119","author":"TI Kam","year":"2022","unstructured":"Kam, T. I. et al. Amelioration of pathologic \u03b1-synuclein-induced Parkinson\u2019s disease by irisin. Proc. Natl Acad. Sci. USA 119, e2204835119 (2022).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"8850_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2023.103555","volume":"41","author":"X Shi","year":"2024","unstructured":"Shi, X. et al. Relationship of irisin with disease severity and dopamine uptake in Parkinson\u2019s disease patients. Neuroimage. Clin. 41, 103555 (2024).","journal-title":"Neuroimage. Clin."},{"key":"8850_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41531-023-00453-9","volume":"9","author":"X Zhang","year":"2023","unstructured":"Zhang, X. et al. Irisin exhibits neuroprotection by preventing mitochondrial damage in Parkinson\u2019s disease. NPJ Parkinsons Dis. 9, 13 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"8850_CR18","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12979-024-00437-0","volume":"21","author":"C Wang","year":"2024","unstructured":"Wang, C. et al. Irisin inhibits microglial senescence via TFAM-mediated mitochondrial metabolism in a mouse model of tauopathy. Immun. Ageing 21, 30 (2024).","journal-title":"Immun. Ageing"},{"key":"8850_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103369","volume":"77","author":"Q Wang","year":"2024","unstructured":"Wang, Q. et al. Microglial CR3 promotes neuron ferroptosis via NOX2-mediated iron deposition in rotenone-induced experimental models of Parkinson\u2019s disease. Redox Biol. 77, 103369 (2024).","journal-title":"Redox Biol."},{"key":"8850_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-02065-z","volume":"18","author":"D Zhang","year":"2021","unstructured":"Zhang, D. et al. Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson\u2019s disease model. J. Neuroinflammation 18, 4 (2021).","journal-title":"J. Neuroinflammation"},{"key":"8850_CR21","first-page":"422","volume":"21","author":"M Mustapha","year":"2021","unstructured":"Mustapha, M. & Mat Taib, C. N. MPTP-induced mouse model of Parkinson\u2019s disease: a promising direction of therapeutic strategies. Bosn. J. Basic Med. Sci. 21, 422\u2013433 (2021).","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"8850_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/apha.14103","volume":"240","author":"H Shi","year":"2024","unstructured":"Shi, H. et al. Exercise-inducible circulating extracellular vesicle irisin promotes browning and the thermogenic program in white adipose tissue. Acta Physiol. 240, e14103 (2024).","journal-title":"Acta Physiol."},{"key":"8850_CR23","doi-asserted-by":"publisher","unstructured":"Pelczy\u0144ska, M. et al. The role of adipokines and myokines in the pathogenesis of different obesity phenotypes\u2014new perspectives. Antioxidants https:\/\/doi.org\/10.3390\/antiox12122046 (2023).","DOI":"10.3390\/antiox12122046"},{"key":"8850_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.962968","volume":"13","author":"S Liu","year":"2022","unstructured":"Liu, S. et al. Role of irisin in physiology and pathology. Front. Endocrinol. 13, 962968 (2022).","journal-title":"Front. Endocrinol."},{"key":"8850_CR25","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/brain\/awad388","volume":"147","author":"Y Chu","year":"2024","unstructured":"Chu, Y. et al. Nigrostriatal tau pathology in parkinsonism and Parkinson\u2019s disease. Brain 147, 444\u2013457 (2024).","journal-title":"Brain"},{"key":"8850_CR26","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1016\/j.ymthe.2017.08.017","volume":"25","author":"KJ McMillan","year":"2017","unstructured":"McMillan, K. J. et al. Loss of microRNA-7 regulation leads to \u03b1-synuclein accumulation and dopaminergic neuronal loss in vivo. Mol. Ther. 25, 2404\u20132414 (2017).","journal-title":"Mol. Ther."},{"key":"8850_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.brainresrev.2008.07.007","volume":"59","author":"L Tapia-Arancibia","year":"2008","unstructured":"Tapia-Arancibia, L., Aliaga, E., Silhol, M. & Arancibia, S. New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Res. Rev. 59, 201\u2013220 (2008).","journal-title":"Brain Res. Rev."},{"key":"8850_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-3-642-45106-5_9","volume":"220","author":"B Lu","year":"2014","unstructured":"Lu, B., Nagappan, G. & Lu, Y. BDNF and synaptic plasticity, cognitive function, and dysfunction. Handb. Exp. Pharmacol. 220, 223\u2013250 (2014).","journal-title":"Handb. Exp. Pharmacol."},{"key":"8850_CR29","doi-asserted-by":"publisher","unstructured":"Palasz, E. et al. BDNF as a promising therapeutic agent in Parkinson\u2019s disease. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21031170 (2020).","DOI":"10.3390\/ijms21031170"},{"key":"8850_CR30","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s11655-018-2579-0","volume":"25","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. & Liang, X. C. Effects of mitochondrial dysfunction via AMPK\/PGC-1 \u03b1 signal pathway on pathogenic mechanism of diabetic peripheral neuropathy and the protective effects of Chinese medicine. Chin. J. Integr. Med. 25, 386\u2013394 (2019).","journal-title":"Chin. J. Integr. Med."},{"key":"8850_CR31","doi-asserted-by":"publisher","unstructured":"Jiang, H. et al. Adult conditional knockout of PGC-1\u03b1 leads to loss of dopamine neurons. eNeuro https:\/\/doi.org\/10.1523\/eneuro.0183-16.2016 (2016).","DOI":"10.1523\/eneuro.0183-16.2016"},{"key":"8850_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-00066-7","volume":"15","author":"K Zhang","year":"2025","unstructured":"Zhang, K., Du, Y., Yang, S. & Sun, G. Irisin suppressed the progression of TBI via modulating AMPK\/MerTK\/autophagy and SYK\/ROS\/inflammatory signaling. Sci. Rep. 15, 15583 (2025).","journal-title":"Sci. Rep."},{"key":"8850_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2020.114953","volume":"394","author":"CJ Huo","year":"2020","unstructured":"Huo, C. J. et al. Irisin lowers blood pressure by activating the Nrf2 signaling pathway in the hypothalamic paraventricular nucleus of spontaneously hypertensive rats. Toxicol. Appl. Pharm. 394, 114953 (2020).","journal-title":"Toxicol. Appl. Pharm."},{"key":"8850_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101108","volume":"62","author":"PL Valenzuela","year":"2020","unstructured":"Valenzuela, P. L. et al. Exercise benefits on Alzheimer\u2019s disease: state-of-the-science. Ageing Res. Rev. 62, 101108 (2020).","journal-title":"Ageing Res. Rev."},{"key":"8850_CR35","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature10777","volume":"481","author":"P Bostr\u00f6m","year":"2012","unstructured":"Bostr\u00f6m, P. et al. A PGC1-\u03b1-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463\u2013468 (2012).","journal-title":"Nature"},{"key":"8850_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2023.110672","volume":"199","author":"C Dai","year":"2023","unstructured":"Dai, C. et al. Glucose metabolism impairment in Parkinson\u2019s disease. Brain Res. Bull. 199, 110672 (2023).","journal-title":"Brain Res. Bull."},{"key":"8850_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/apha.14211","volume":"240","author":"Y Cui","year":"2024","unstructured":"Cui, Y. et al. Irisin preserves mitochondrial integrity and function in tubular epithelial cells after ischemia-reperfusion-induced acute kidney injury. Acta Physiol. 240, e14211 (2024).","journal-title":"Acta Physiol."},{"key":"8850_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2024.110991","volume":"213","author":"Y Su","year":"2024","unstructured":"Su, Y. et al. The molecular mechanism of ferroptosis and its relationship with Parkinson\u2019s disease. Brain Res. Bull. 213, 110991 (2024).","journal-title":"Brain Res. Bull."},{"key":"8850_CR39","doi-asserted-by":"publisher","first-page":"112656","DOI":"10.1016\/j.biopha.2022.112656","volume":"147","author":"R Kumar","year":"2022","unstructured":"Kumar, R., T, A., Singothu, S., Singh, S. B. & Bhandari, V. Uncoupling proteins as a therapeutic target for the development of new era drugs against neurodegenerative disorder. Biomed. Pharmacother. 147, 112656 (2022).","journal-title":"Biomed. Pharmacother."},{"key":"8850_CR40","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1523\/JNEUROSCI.4269-04.2005","volume":"25","author":"ZB Andrews","year":"2005","unstructured":"Andrews, Z. B. et al. Uncoupling protein-2 is critical for nigral dopamine cell survival in a mouse model of Parkinson\u2019s disease.  J. Neurosci. 25, 184\u2013191 (2005).","journal-title":"J. Neurosci."},{"key":"8850_CR41","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s12640-021-00392-4","volume":"39","author":"Y Chen","year":"2021","unstructured":"Chen, Y., Jiang, Y., Yang, Y., Huang, X. & Sun, C. SIRT1 protects dopaminergic neurons in Parkinson\u2019s disease models via PGC-1\u03b1-mediated mitochondrial biogenesis. Neurotox. Res. 39, 1393\u20131404 (2021).","journal-title":"Neurotox. Res."},{"key":"8850_CR42","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.bbrc.2016.01.013","volume":"470","author":"SY Dong","year":"2016","unstructured":"Dong, S. Y. et al. The epigenetic regulation of HIF-1\u03b1 by SIRT1 in MPP(+) treated SH-SY5Y cells. Biochem. Biophys. Res. Commun. 470, 453\u2013459 (2016).","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08850-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08850-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08850-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:34:18Z","timestamp":1761928458000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08850-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8850"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08850-x","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"assertion":[{"value":"3 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1516"}}